LEONE ELLIOTT: Open Payments
NPI 1609805381 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 25 payments from 11 companies in 2025. Trend: 2023 $192 · 2024 $196 · 2025 $739
Food & beverage: $723Gift: $16
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $206 |
| Janssen Pharmaceuticals, Inc | 5 | $135 |
| Gilead Sciences, Inc. | 1 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| ABBVIE INC. | 2 | $38 |
| Lundbeck LLC | 1 | $30 |
| Boston Scientific Corporation | 2 | $29 |
| TOLMAR, INC. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Purdue Pharma L.P. | 1 | $16 |
Products named: SUBLOCADE, SPRAVATO, Epclusa, CAPLYTA, VRAYLAR, REXULTI, General - Vascular Intervention, JATENZO.
Industry payments across LA — which companies pay providers there.
